March 7, 2017

Alimera Sciences to Present at the 29th Annual ROTH Conference

ATLANTA, March 07, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the commercialization, research and development of prescription ophthalmic pharmaceuticals, today announced that Chief Executive Officer, Dan Myers, will present at the 29th Annual ROTH Conference, to be held March 12-15, 2017 at the Ritz Carlton, Orange County, CA. The Company's presentation will take place Wednesday, March 15, 2017, at 10:00 AM Pacific Time.

A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Relations" section of the Company's website at www.alimerasciences.com. A replay of the conference presentation will also be available.

About Alimera Sciences

Alimera Sciences, founded in June 2003, is a pharmaceutical company that specializes in the commercialization, research and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. For more information, please visit www.alimerasciences.com.

Contact:

CG CAPITAL

877.889.1972

investorrelations@cg.capital

cg.capital

Primary Logo

Source: Alimera Sciences, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Alimera Sciences, Inc.